You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GPCR Sale Disclosure
Lin Xichen · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$41.97K
Lin Xichen Chief Scientific Officer
GPCR
Transaction date
Aug 4, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 1 day later
GPCR daily price context
Close on/before transaction
$49.64
Aug 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- American Depositary Shares on Ordinary Shares
- Quantity / price
- 839 shares @ $50.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001962926-26-000007
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$198.78K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Structure Therapeutics Inc. GPCR | Conversion | Aug 4, 2026 | $0 |
| Structure Therapeutics Inc. GPCR Current | Sale | Aug 4, 2026 | $41.97K |
| Structure Therapeutics Inc. GPCR | Exercise | Aug 4, 2026 | $4.02K |
| Structure Therapeutics Inc. GPCR | Exercise | Aug 4, 2026 | $0 |
| Structure Therapeutics Inc. GPCR | Conversion | Aug 4, 2026 | $0 |
| Structure Therapeutics Inc. GPCR | Sale | Aug 4, 2026 | $152.79K |